SiRNA inhibition of ER-α expression reduces KGF-induced proliferation of breast cancer cells

Anticancer Research

Volumn 28, Issue 5 A, 2008, Pages 2733-2735

  Zang, Xiao Ping ^a   Pento, J Thomas ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Cell proliferation; ER; KGF; MCF 7; siRNA

Indexed keywords

BETA ACTIN; ESTROGEN RECEPTOR ALPHA; KERATINOCYTE GROWTH FACTOR; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL STRUCTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR 7; HUMANS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 55749110592     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S and Aaronson SA: Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86: 802-806, 1989.
2. Rubin JS, Bottaro DP, Chedid M, Mikki T, Ron D, Cunha G and Finch PW: Epithelial-mesenchymal interactions in cancer. Verlag Basel, pp. 191-214, 1995.
3. Aaronson SA, Bottaro DP, Miki T, Ron D, Finch PW, Fleming TP, Ahn J, Taylor WG and Rubin JS: Keratinocyte growth factor. A fibroblast growth factor family member with unusual target cell specificity. Ann NY Acad Sci 638: 62-77, 1991.
4. Bottaro DP, Rubin JS, Ron D, Finch PW, Florio C and Aaronson SA: Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J Biol Chem 265: 12767-12770, 1990.
5. Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cheon G, Taylor WG, Fortney E, Sakata H, Finch PW et al: Keratinocyte growth factor. Cell Biol Int 19: 399-411, 1995.
6. Ulich TR, Yi ES, Cardiff R, Yin S, Bikhazi N, Biltz R, Morris CF and Pierce GF: Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. The mammary epithelium of lactating rats is resistant to the proliferative action of keratinocyte growth factor. Am J Pathol 144: 862-868, 1994.
7. Kitsberg DI and Leder P: Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene 13: 2507-2515, 1996.
8. Palmieri C, Roberts-Clark D, Assadi-Sabet A, Coope RC, O'Hare M, Sunters A, Hanby A, Slade MJ, Gomm JJ, Lam EW and Coombes RC: Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cells. J Endocrinol 177: 65-81, 2003.
9. Koos RD, Banks PK, Inkster SE, Yue W and Brodie AM: Detection of aromatase and keratinocyte growth factor expression in breast tumors using reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol 45: 217-225, 1993.
10. Bansal GS, Cox HC, Marsh S, Gomm JJ, Yiangou C, Luqmani Y, Coombes RC and Johnston CL: Expression of keratinocyte growth factor and its receptor in human breast cancer. Br J Cancer 75: 1567-1574, 1997.
11. Zang XP and Pento JT: Keratinocyte growth factor-induced motility of breast cancer cells. Clin Exp Metastasis 18: 573-580, 2001.
12. Zang XP, Bullen EC, Manjeshwar S, Jupe ER, Howard EW and Pento JT: Enhanced motility of KGF-transfected breast cancer cells. Anticancer Res 26: 961-966, 2006.
13. Zang XP, Learner ML, Brackett DJ and Pento JT: KGF-induced gene expression in MCF-7 cells using cDNA expression arrays. Breast Cancer Res Treat 64: 110, 2000.
14. Zang XP, Siwak D, Nguyen TX, Tari AM and Pento JT: KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2. Clin Exptl Metastasis 21: 437-443, 2004.
15. Zang XP, Lerner MR, Dunn ST, Brackett DJ and Pento JT: Antisense KGFR oligonucleotide inhibition of KGF-induced motility in breast cancer cells. Anticancer Res 23: 4913-4919, 2003.
16. Rajah TT, Rambo DJ, Dmytryk JJ and Pento JT: Influence of antiestrogens on NIH-3T3-fibroblast-induced motility of breast cancer cells. Chemotherapy 47: 56-69, 2001.
17. Nunez AM, Berry M, Imler JL and Chambon P: The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J 8: 823-829, 1989.
18. Yarden RI, Lauber AH, El-Ashry D and Chrysogelos SA: Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. Endocrinology 137: 2739-2147, 1996.
19. Clarke RB: Complementary yet distinct roles for oestrogen receptor-alpha and oestrogen receptor-beta in mouse mammary epithelial proliferation. Breast Cancer Res 6: 135-136, 2004.